Imiglucerase biosimilar (ISU Abxis/GC Pharma)

伊米苷酶生物类似物 (ISU Abxis/GC Pharma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameImiglucerase biosimilar (ISU Abxis/GC Pharma)
Drug Alias NameSelezyme (ISU Abxis/GC Pharma)伊米苷酶生物仿制药 (ISU Abxis/GC Pharma)Imiglucerasa (ISU Abxis/GC Pharma)Cerecyme (ISU Abxis/GC Pharma)Imiglucerasum (ISU Abxis/GC Pharma) +[7] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar
Mechanisms of Actionglucocerebroside hydrolysis activatorsGlucosylceramidase replacements
TargetsGlucosylceramide
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsGaucher Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2012/01/01
Country/TerritoryAustraliaIranSouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesIsu Abxis Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIsu Abxis Co Ltd
Inactive CompaniesN/A
Active IndicationsGaucher Disease
Inactive IndicationsN/A

Other Information

ATC CodeA16AB02
Related LinksN/A